Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6373.0000 -89.50 (-1.38%)
NSE Nov 21, 2025 15:31 PM
Volume: 130.8K
 

6373.00
-1.38%
ICICI Securities Limited
The USFDA has communicated to Divi's Laboratories its intention to lift the import alert '99-32'' imposed on unit-II (that includes EOU, SEZ and DSN SEZ) of the Vizag API plant. USFDA had inspected this plant between November 29 and December 6, 2016 and issued a Form 483 to the unit with five observations. Subsequently, an import alert was issued to the products manufactured at unit-II under clauses 66-40 and 99-32, with an exemption for 12 products (10 products initially exempted and then two added later on), followed by a warning letter to the plant in May 2017....
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6221.0
More from Divi's Laboratori…
All earning calls
Investor presentations from Divi's Laboratori…
All investor presentations